福泰制药(VRTX)：高级副总裁提高了指导预期至106.5亿至108.5亿美元，反映出9%的增长

市场资讯

2024-09-19

来源：Gangtise投研

福泰制药(VRTX) 在2024年的Jefferies工业会议上，高级副总裁Susie Lisa讨论了公司的当前状况和未来方向。她强调了公司在囊性纤维化（CF）治疗领域的强劲商业执行力，并提高了指导预期至106.5亿至108.5亿美元，反映出9%的增长。Lisa还提到了公司在疼痛治疗领域的多元化商业战略，特别是在慢性疼痛和外周神经性疼痛方面的进展，以及公司在糖尿病细胞疗法方面的研究。此外，她提到了公司对Alpine Immune Sciences的收购，这将加强公司在自身免疫疾病领域的地位。Lisa对公司的长期增长潜力持乐观态度，并强调了公司在生产力提升和资源分配方面的战略重点。

海量资讯、精准解读，尽在新浪财经APP

责任编辑：张倩

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2468593967"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2468593967\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2468593967?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2024-09-19 08:57","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2468593967","market":"other","top_or_hot":-1,"title":"福泰制药(VRTX)：高级副总裁提高了指导预期至106.5亿至108.5亿美元，反映出9%的增长","media":"市场资讯","content":"<html><body><div>\n<p><strong><span>来源：Gangtise投研</span></strong></p>\n<p><strong><span><a href=\"https://laohu8.com/S/VRTX\">福泰制药</a>(VRTX) </span></strong><span>在2024年的Jefferies工业会议上，高级副总裁Susie Lisa讨论了公司的当前状况和未来方向。她强调了公司在囊性纤维化（CF）治疗领域的强劲商业执行力，</span><strong><span>并提高了指导预期至106.5亿至108.5亿美元，反映出9%的增长。</span></strong><span>Lisa还提到了公司在疼痛治疗领域的多元化商业战略，</span><strong><span>特别是在慢性疼痛和外周神经性疼痛方面的进展，以及公司在糖尿病细胞疗法方面的研究。</span></strong><span>此外，她提到了</span><strong><span>公司对Alpine Immune Sciences的收购，这将加强公司在自身免疫疾病领域的地位。</span></strong><span>Lisa对公司的长期增长潜力持乐观态度，并强调了公司在生产力提升和资源分配方面的战略重点。</span></p>\n<div></div>\n<div>\n<div><img src=\"\"/></div>\n<div>海量资讯、精准解读，尽在新浪财经APP</div>\n</div>\n<p>责任编辑：张倩 </p>\n</div></body></html>","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>福泰制药(VRTX)：高级副总裁提高了指导预期至106.5亿至108.5亿美元，反映出9%的增长</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n福泰制药(VRTX)：高级副总裁提高了指导预期至106.5亿至108.5亿美元，反映出9%的增长\n</h2>\n<h4 class=\"meta\">\n\n\n2024-09-19 08:57 北京时间   <a href=\"https://finance.sina.com.cn/stock/2024-09-19/doc-incprwmu7159855.shtml\"><strong>市场资讯</strong></a>\n</h4>\n</header>\n<article>\n<div>\n<p>来源：Gangtise投研\n福泰制药(VRTX) 在2024年的Jefferies工业会议上，高级副总裁Susie Lisa讨论了公司的当前状况和未来方向。她强调了公司在囊性纤维化（CF）治疗领域的强劲商业执行力，并提高了指导预期至106.5亿至108.5亿美元，反映出9%的增长。Lisa还提到了公司在疼痛治疗领域的多元化商业战略，特别是在慢性疼痛和外周神经性疼痛方面的进展，以及公司在糖尿病细胞...</p>\n<a href=\"https://finance.sina.com.cn/stock/2024-09-19/doc-incprwmu7159855.shtml\">网页链接</a>\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0417517546.SGD","symbol_name":"Allianz US Equity Cl AT Acc SGD","start_time":0,"source_url":"https://finance.sina.com.cn/stock/2024-09-19/doc-incprwmu7159855.shtml","article_id":"2468593967","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2468593967","pubTimestamp":1726707420,"columns":[],"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"福泰制药在2024年的Jefferies工业会议上，高级副总裁Susie Lisa讨论了公司的当前状况和未来方向。她强调了公司在囊性纤维化治疗领域的强劲商业执行力，并提高了指导预期至106.5亿至108.5亿美元，反映出9%的增长。Lisa还提到了公司在疼痛治疗领域的多元化商业战略，特别是在慢性疼痛和外周神经性疼痛方面的进展，以及公司在糖尿病细胞疗法方面的研究。Lisa对公司的长期增长潜力持乐观态度，并强调了公司在生产力提升和资源分配方面的战略重点。","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU0417517546.SGD":"Allianz US Equity Cl AT Acc SGD","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC","LU0079474960.USD":"联博美国增长基金A","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","IE00B894F039.SGD":"Legg Mason ClearBridge - US Aggressive Growth A Acc SGD-H","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","LU2362540622.SGD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (SGDHDG) ACC","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","IE00B19Z9P08.USD":"LEGG MASON CLEARBRIDGE US AGGRESSIVE GROWTH \"A\" (USD) INC","LU1069344957.HKD":"AB SICAV I - AMERICAN GROWTH PORTFOLIO \"AD\" (HKD) INC","LU0058720904.USD":"联博国际健康护理基金A","LU2237438978.USD":"Amundi Funds US Pioneer A2 (C) USD","IE00B19Z9Z06.USD":"Legg Mason ClearBridge - US Aggressive Growth A Acc USD","BK4532":"文艺复兴科技持仓","LU2236285917.USD":"ALLIANZ GLOBAL INCOME \"AMG\" (USD) INC","LU1430594728.SGD":"Eastspring Investments - Global Low Volatility Equity AS SGD","BK4585":"ETF&股票定投概念","BK4567":"ESG概念","LU2417539215.USD":"ALLIANZ GLOBAL INCOME \"AMF\" (USD) INC","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","BK4139":"生物科技","BK4533":"AQR资本管理(全球第二大对冲基金)","LU0061475181.USD":"THREADNEEDLE (LUX) AMERICAN \"AU\" (USD) ACC","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","LU2456880835.USD":"ALLIANZ GLOBAL INCOME \"AT\" (USD) ACC","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","LU2362541273.HKD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (HKD) ACC","LU2462157665.USD":"ALLIANZ GLOBAL INCOME \"A\" (USD) INC","LU0256863811.USD":"ALLIANZ US EQUITY \"A\" INC","LU1035775433.USD":"AB SICAV I - AMERICAN GROWTH PORTFOLIO \"AD\" (USD) INC","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","IE00BZ9MQY76.HKD":"FTGF CLEARBRIDGE US AGGRESSIVE GROWTH \"A\" (HKD) ACC","LU2362541513.USD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (USD) ACC","LU1585245621.USD":"EASTSPRING INV GLOBAL LOW VOLATILITY EQUITY FUND \"A\" (USD) ACC B","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","BK4588":"碎股","LU0823416689.USD":"BNP PARIBAS HEALTH CARE INNOVATORS \"C\" (USD) ACC","VRTX":"福泰制药","LU0234570918.USD":"高盛全球核心股票组合Acc Close"},"translate_title":"Fortex Pharmaceuticals (VRTX): SVP Raises Guidance Estimate to $10.65 Billion to $10.85 Billion, Reflecting 9% Growth","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VRTX":1},"content_text":"来源：Gangtise投研\n福泰制药(VRTX) 在2024年的Jefferies工业会议上，高级副总裁Susie Lisa讨论了公司的当前状况和未来方向。她强调了公司在囊性纤维化（CF）治疗领域的强劲商业执行力，并提高了指导预期至106.5亿至108.5亿美元，反映出9%的增长。Lisa还提到了公司在疼痛治疗领域的多元化商业战略，特别是在慢性疼痛和外周神经性疼痛方面的进展，以及公司在糖尿病细胞疗法方面的研究。此外，她提到了公司对Alpine Immune Sciences的收购，这将加强公司在自身免疫疾病领域的地位。Lisa对公司的长期增长潜力持乐观态度，并强调了公司在生产力提升和资源分配方面的战略重点。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张倩","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0}}}